PharmaNews.eu
  • Home
  • Business
  • R&D
  • EC
  • EMA
  • Events
  • Open Calls

Bayer

The Bayer GroupThe Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subsidiary of Bayer AG, is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Diabetes Care and Pharmaceuticals divisions. The pharmaceuticals business operates under the name Bayer Schering Pharma. Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide. Find more information at www.bayerhealthcare.com.

Bayer Schering Pharma is a worldwide leading specialty pharmaceutical company. Its research and business activities are focused on the following areas: Diagnostic Imaging, General Medicine, Specialty Medicine and Women's Healthcare. With innovative products, Bayer Schering Pharma aims for leading positions in specialized markets worldwide. Using new ideas, Bayer Schering Pharma aims to make a contribution to medical progress and strives to improve the quality of life. Find more information at www.bayerscheringpharma.de.

Bayer RSS Channel

Filters
List of articles in category Bayer
Title Published Date
Bayer and Dewpoint Therapeutics partner to research new treatments for cardiovascular and gynecological diseases 15 November 2019
Bayer Launches LifeHub UK Focused on Artificial Intelligence to Optimize Data-Driven Drug Discovery and Disease Diagnosis 18 October 2019
Bayer inks deals with eleven startups under G4A Digital Health Partnerships program 11 October 2019
Bayer, Brigham and Women’s Hospital, and Massachusetts General Hospital open joint lab for research of new treatments for chronic lung diseases 24 September 2019
Bayer acquires BlueRock Therapeutics to build leading position in cell therapy 08 August 2019
LEO Pharma completes the acquisition of Bayer’s prescription dermatology business 03 July 2019
Regorafenib to be tested in brain cancer patients in multi-arm cooperation trial 21 June 2019
Bayer reaches settlement to resolve Xarelto™ litigation 25 March 2019
Bayer is taking collaboration with health care start-ups to the next level 21 March 2019
Bayer accelerates six new startups 30 August 2018
Bayer Cares Foundation promotes sustainable growth by supporting social impact pioneers with grants totaling EUR 1 million 06 August 2018
XANTUS programme confirms low bleeding and low stroke rate with Xarelto® in 11,121 prospectively investigated patients with atrial fibrillation 10 July 2018
Combining tradition with modernity: Bayer hones its brand profile 04 April 2018
New scholarships worth EUR 417,000 awarded by Bayer Foundation to promote international talents 22 September 2017
Bayer receives EU approval for Stivarga® (Regorafenib) for the second-line systemic treatment of liver cancer 07 August 2017
"Green light" for Bayer's new transparent low dose contraceptive patch 11 February 2014
Bayer receives approval for new cancer drug Xofigo® 18 November 2013
Bayer completes acquisition of Steigerwald 01 July 2013
Bayer HealthCare joins forces with Stroke Alliance for Europe 07 May 2013
Bayer HealthCare to broaden strategic alliance with German Cancer Research Center 11 April 2013

Page 2 of 5

  • Start
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next
  • End
  1. You are here:  
  2. Home
  3. Bayer

About

  • Home
  • Terms and Conditions
  • Contact

Advertise

Top News Channels

  • Business
  • Research
  • EMA
  • Events

Follow us

Didn't we got you connected? If not, please note the following magic buttons:

  • Facebook
  • Twitter
  • RSS 2.0
  • Atom 1.0

Newsletter

Stay updated on the latest Pharma News. Subscribe now, it's free!

Copyright © 2023 PharmaNews.eu. All Rights Reserved.